<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ar">
	<id>https://www.arabsciencepedia.org/w/index.php?action=history&amp;feed=atom&amp;title=%D9%81%D9%88%D8%B3%D8%AA%D9%8A%D8%AF%D9%8A%D9%84</id>
	<title>فوستيديل - تاريخ المراجعة</title>
	<link rel="self" type="application/atom+xml" href="https://www.arabsciencepedia.org/w/index.php?action=history&amp;feed=atom&amp;title=%D9%81%D9%88%D8%B3%D8%AA%D9%8A%D8%AF%D9%8A%D9%84"/>
	<link rel="alternate" type="text/html" href="https://www.arabsciencepedia.org/w/index.php?title=%D9%81%D9%88%D8%B3%D8%AA%D9%8A%D8%AF%D9%8A%D9%84&amp;action=history"/>
	<updated>2026-04-13T07:52:33Z</updated>
	<subtitle>تاريخ التعديل لهذه الصفحة في الويكي</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://www.arabsciencepedia.org/w/index.php?title=%D9%81%D9%88%D8%B3%D8%AA%D9%8A%D8%AF%D9%8A%D9%84&amp;diff=26013&amp;oldid=prev</id>
		<title>أسيل سيوف: أنشأ الصفحة ب&#039;{{Drugbox | IUPAC_name = diethyl [4-(1,3-benzothiazol-2-yl)benzyl]phosphonate | image = Fostedil_structure.png  &lt;!--Clinical data--&gt; | tradename =   | pregnancy_category...&#039;</title>
		<link rel="alternate" type="text/html" href="https://www.arabsciencepedia.org/w/index.php?title=%D9%81%D9%88%D8%B3%D8%AA%D9%8A%D8%AF%D9%8A%D9%84&amp;diff=26013&amp;oldid=prev"/>
		<updated>2013-06-01T19:51:05Z</updated>

		<summary type="html">&lt;p&gt;أنشأ الصفحة ب&amp;#039;{{Drugbox | IUPAC_name = diethyl [4-(1,3-benzothiazol-2-yl)benzyl]phosphonate | image = Fostedil_structure.png  &amp;lt;!--Clinical data--&amp;gt; | tradename =   | pregnancy_category...&amp;#039;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;صفحة جديدة&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Drugbox&lt;br /&gt;
| IUPAC_name = diethyl [4-(1,3-benzothiazol-2-yl)benzyl]phosphonate&lt;br /&gt;
| image = Fostedil_structure.png&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| pregnancy_category =  &lt;br /&gt;
| legal_status = Uncontrolled&lt;br /&gt;
| routes_of_administration = Oral&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability =  &lt;br /&gt;
| metabolism =  &lt;br /&gt;
| elimination_half-life =  &lt;br /&gt;
| excretion =  &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number = 75889-62-2&lt;br /&gt;
| ATC_prefix = none&lt;br /&gt;
| ATC_suffix =  &lt;br /&gt;
| PubChem = 53421&lt;br /&gt;
| ChemSpiderID = 48253&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = D41WS786UL&lt;br /&gt;
| KEGG = D04260&lt;br /&gt;
| ChEMBL = 39516&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=18 | N=1 | O=3 | P=1 | S=1 &lt;br /&gt;
| molecular_weight = 361.40 g/mol&lt;br /&gt;
| smiles = O=P(OCC)(OCC)Cc3ccc(c1nc2ccccc2s1)cc3&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;فوستيديل Fostedil&amp;#039;&amp;#039;&amp;#039; هو موسع وعائي يعمل كحاصر لقنوات الكالسيوم، وكان في طور التطوير لعلاج حالات القلب (كالذبحة الصدرية) ولكنه لم يسوق.&amp;lt;ref name=&amp;quot;isbn0-412-46630-9&amp;quot;&amp;gt;{{cite book | author = David J. Triggle | title = Dictionary of Pharmacological Agents | publisher = Chapman &amp;amp; Hall/CRC | location = Boca Raton | year = 1996 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = http://books.google.com/?id=DeX7jgInYFMC&amp;amp;lpg=PA931&amp;amp;dq=Fostedil&amp;amp;pg=PA931#v=onepage&amp;amp;q}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid3902675&amp;quot;&amp;gt;{{cite journal | author = Khurmi NS, Bowles MJ, O&amp;#039;Hara MJ, Lahiri A, Raftery EB | title = Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris | journal = International Journal of Cardiology | volume = 9 | issue = 3 | pages = 289–302 | year = 1985 | month = November | pmid = 3902675 | doi = 10.1016/0167-5273(85)90027-0| url = }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid6890822&amp;quot;&amp;gt;{{cite journal | author = Morita T, Yoshino K, Kanazawa T, Ito K, Nose T | title = Vasodilator action of KB-944, a new calcium antagonist | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1037–42 | year = 1982 | pmid = 6890822 | doi = | url = }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid6890823&amp;quot;&amp;gt;{{cite journal | author = Morita T, Kanazawa T, Ito K, Nose T | title = Vasodilator mechanism of KB-944, a new calcium antagonist | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1043–6 | year = 1982 | pmid = 6890823 | doi = | url = }}&amp;lt;/ref&amp;gt; &lt;br /&gt;
له تأثير [[خافض للضغط]] و[[مضاد للروماتيزم]].&amp;lt;ref name=&amp;quot;pmid6890824&amp;quot;&amp;gt;{{cite journal | author = Morita T, Kanazawa T, Ito K, Nose T | title = Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1047–52 | year = 1982 | pmid = 6890824 | doi = | url = }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid6890825&amp;quot;&amp;gt;{{cite journal | author = Morita T, Ito K, Nose T | title = Cardiac action of KB-944, a new calcium antagonist | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1053–5 | year = 1982 | pmid = 6890825 | doi = | url = }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid6890826&amp;quot;&amp;gt;{{cite journal | author = Yoshidomi M, Sukamoto T, Morita T, Ito K, Nose T | title = Antiarrhythmic effect of KB-944, a new calcium antagonist. A comparison with verapamil and diltiazem | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1056–9 | year = 1982 | pmid = 6890826 | doi = | url = }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==الاسماء التجارية==&lt;br /&gt;
&lt;br /&gt;
*986,A-53&lt;br /&gt;
*KB-944&lt;br /&gt;
&lt;br /&gt;
==الاصطناع==&lt;br /&gt;
&lt;br /&gt;
[[Image:Fostedil.png|500px]]&amp;lt;ref name=&amp;quot;pmid3701791&amp;quot;&amp;gt;{{cite journal | author = Yoshino K, Kohno T, Uno T, Morita T, Tsukamoto G | title = Organic phosphorus compounds. 1. 4-(Benzothiazol-2-yl)benzylphosphonate as potent calcium antagonistic vasodilator | journal = Journal of Medicinal Chemistry | volume = 29 | issue = 5 | pages = 820–5 | year = 1986 | month = May | pmid = 3701791 | doi = 10.1021/jm00155a037| url = }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==مصادر==&lt;br /&gt;
&lt;br /&gt;
{{ثبت المراجع}}&lt;br /&gt;
&lt;br /&gt;
{{بذرة}}&lt;br /&gt;
{{حاصرات قنوات الكالسيوم}}&lt;br /&gt;
&lt;br /&gt;
[[تصنيف:أدوية]]&lt;br /&gt;
[[تصنيف:موسوعة الأدوية]]&lt;br /&gt;
[[تصنيف:حاصرات قنوات الكالسيوم]]&lt;/div&gt;</summary>
		<author><name>أسيل سيوف</name></author>
	</entry>
</feed>